Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 209-378-3 | CAS number: 574-93-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
- Endpoint:
- basic toxicokinetics in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 2018
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Objective of study:
- other: abiotic dissolution
- Principles of method if other than guideline:
- - Principle of test:
Abiotic flow-through method:
For the determination of the abiotic dissolution the established flow-through testing of the dissolution kinetics of mineral fibers (Guldberg et al., 1995; IARC, 2002) was used with the following adaptations:
- 1 mg of the test material was weighed onto a membrane (cellulose triacetate, Sartorius Stedim Biotech GmbH, Goettingen, Germany): 47mm diameter, 5 kDa pore size, topped by another membrane, and enclosed in flow-through cells.
- Standard conditions are 1 mg initial solid mass in the flow-through cell, and 2 mL/h flow.
- The phagolysosomal simulant fluid (PSF), an acidic buffer simulating the phagolysosomal compartment of macrophages was employed at 37 ± 0.5 °C.
The ion concentrations of the eluates from different time points were determined by inductively coupled plasma-optical emission spectrometry (ICP-OES Agilent 5100 and Varian 725 ES) with a limit of detection of 0.1 mg/L or by inductively coupled plasma-mass spectrometry (ICP-MS Perkin Elmer Nexion 2000b) with a limit of detection of 0.1 ppb. Duplicate measurements were taken and averaged.
After the experiment, the remaining solids were rinsed off the membrane and the resulting suspension was then pelleted onto a TEM grid held at the bottom of a centrifuge vial within 30 min, then dried for the inspection of the morphology of the remaining solids.
- Parameters analysed / observed: dissolution (based on ion concentrations), morphology of the remaining solids
Guldberg, M., et al., 1995. Method for determining in-vitro dissolution rates of man-made vitreous fibres. Glas. Sci. Technol. 68 (6), 181–187.
IARC, I.A.F.R.O.C, 2002. Man-made Vitreous Fibres. World Health Organization, pp. 1–433. - GLP compliance:
- not specified
- Specific details on test material used for the study:
- - Name as cited in the publication: Cu_Phthalocyanine_nano (Pigment Blue 15)
- Source: BASF SE - Radiolabelling:
- no
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Reason / purpose for cross-reference:
- reference to same study
- Objective of study:
- distribution
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- The study examined, whether or not systemic absorption of copper occured after 90-day high dose feed exposure to the test material. Copper analyses were conducted in livers and kidneys of the animals.
- GLP compliance:
- no
- Specific details on test material used for the study:
- - Analytical purity: The chemical analysis, performed at Midwest Research Institute indicated that the purity was 104.7 % +- 1.1 % (elemental analysis)
- Radiolabelling:
- no
- Species:
- rat
- Strain:
- Fischer 344
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Industries
- Weight at study initiation: males: 70 - 105 g; females: 70 - 100 g
- Housing: polycarbonate cages: groups of 5 rats per cage
- Diet: weighed portions of Purina Lab Chow in meal form, mixed together with weighed portions of the test material (see details at "doses/concentrations")
- Water: ad libitum
- Acclimation period: 15 days
ENVIRONMENTAL CONDITIONS
- Temperature: 21 - 23 °C
- Humidity: 40 - 60 %
- Air changes: at least 15 per hour
- Photoperiod: 12 hrs dark / 12 hrs light - Route of administration:
- oral: feed
- Vehicle:
- other: 12 % water was added to the test material as a dust control agent
- Details on exposure:
- Dose levels of 5.0, 2.5, 1.25, 0.6 and 0.3 % (w/w) were selected for both males and females. The selected doses were prepared by mixing weighed portions of purina Lab Chow in meal form with weighed portions of the test material. 12 % water was added to the test material as a dust control agent prior to mixing with the meal. For each dose level, one weekly lot of 4500 g (+ 12 % water compensation) was prepared.
The actual mixtures were composed of the following ingredients:
- Dose level 5.0 % (w/w): 252 g test material and water + 4275 g meal
- Dose level 2.5 % (w/w): 126 g test material and water + 4387.5 g meal
- Dose level 1.25 % (w/w): 63 g test material and water + 4443.75 g meal
- Dose level 0.6 % (w/w): 30.24 g test material and water + 44735 g meal
- Dose level 0.3 % (w/w): 15.12 g test material and water + 4486.5 g meal
Each diet was mixed in a Patterson-Kelly twin shelled V blender for 15 min.
The doses were mixed one or two days prior to the week of their use in the study, and stored at 23 °C.
One analysis was perfomed to determine the accuracy of the mixture concentration. - Duration and frequency of treatment / exposure:
- 90 days
- Dose / conc.:
- 0.3 other: % in the diet
- Dose / conc.:
- 0.6 other: % in the diet
- Dose / conc.:
- 1.25 other: % in the diet
- Dose / conc.:
- 2.5 other: % in the diet
- Dose / conc.:
- 5 other: % in the diet
- No. of animals per sex per dose / concentration:
- 10 males per dose and 10 females per dose
- Control animals:
- yes, plain diet
- Details on study design:
- The concentrations of the chemical mixture were the same for male and female rats. All dose levels were prepared on a weight per weight basis. There were 5 dose level groups with 10 individuals of each sex in each dosage and control group. Each dosed group received 90 consecutive days of dosed feed mixture. After one day of observation, the animals were necropsied. Animals were observed twice each day for clinical signs, with at least 6 hours between observations. All observations were recorded daily. Additionally, blood sampling was conducted from 10 control rats, 6 males and 4 females.
Copper analyses were completed in the liver and kidney tissues and the formalin preserving those tissues from male rats in the highest dose group (5 % w/w) and control groups:
- Tissue samples were prepared for analysis by digesting in 10 ml of concentrated nitric acid until most of the organic material was destroyed. Perchloric acid was then added and the solutions were evaporated to strong fumes, additional nitric acid being added as required. The solutions were then fumed to dryness, the residues were dissolved in 5 % nitric acid and the solutions were diluted to 10 ml.
- Formalin samples were filtered through a Millex-GS 0.22 µm filter unit and 5 ml portions of each sample were prepared for analysis by the procedure used to prepare the tissue samples.
- The samples were then subjected to atomic absorption spectrophotometry to determine copper content:
A Perkin-Elmer Model 5000 atomic absorption spectrophotometer was utilized for the work. A series of 10 ml standard solutions, ranging from 0.05 to 2.0 ppm were prepared in 5 % nitric acid by dilution of a certified standard copper stock solution. These solutions were used to calibrate the instrument, which was programmed to print out data as total microgramms of copper per sample. The prepared sample solutions were used in the same manner as the standards. Concentrations of copper in the tissue samples were calculated by dividing the total microgramms found by the weight of the sample. Concentrations of copper in the formalin samples were calculated on a volume basis. - Details on dosing and sampling:
- PHARMACOKINETIC STUDY (distribution)
- Tissues and body fluids sampled: liver and kidneys - Statistics:
- Student´s T-test (alpha = 0.05) was used to compare the highest dose group results with control results.
- Details on absorption:
- No data given.
- Details on distribution in tissues:
- No statistically significant increase of residual copper incorporation was neither reported for the liver tissues (2.82 ppm +- 0.34 ppm) nor for the kidney tissues (5.62 ppm +- 0.49 ppm) of the treated male rats of the highest dose group, compared to residual copper incorporation found in controls (liver 2.78 ppm +- 0.51 ppm; kidney 5.30 ppm +- 0.83 ppm). From all the formalin analyses performed, the authors drawed the conclusion that no detectable levels of copper were leached from the preserved tissue into the formalin bath.
- Details on excretion:
- No data given.
- Metabolites identified:
- not measured
- Details on metabolites:
- No data given.
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Reason / purpose for cross-reference:
- reference to same study
- Objective of study:
- distribution
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- The study examined, whether or not systemic absorption of copper occured after 90 day high dose feed exposure to the test material. Copper analyses were conducted in livers and kidneys of the animals.
- GLP compliance:
- no
- Specific details on test material used for the study:
- - Analytical purity: The chemical analysis, performed at Midwest Research Institute indicated that the purity was 104.7 % +- 1.1 % (elemental analysis)
- Radiolabelling:
- no
- Species:
- mouse
- Strain:
- B6C3F1
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Industries
- Age at study initiation: 8.5 weeks
- Weight at study initiation: males: 16 - 23 g; females: 16 - 19 g
- Housing: polycarbonate cages: groups of 5 mice per cage
- Diet: weighed portions of Purina Lab Chow in meal form, mixed together with weighed portions of the test material (see details at "doses/concentrations")
- Water: ad libitum
- Acclimation period: 15 days
ENVIRONMENTAL CONDITIONS
- Temperature: 21 - 23 °C
- Humidity: 40 - 60 %
- Air changes: at least 15 per hour
- Photoperiod: 12 hrs dark / 12 hrs light - Route of administration:
- oral: feed
- Vehicle:
- other: 12 % water was added to the test material as a dust control agent
- Details on exposure:
- Dose levels of 5.0, 2.5, 1.25, 0.6 and 0.3 % (w/w) were selected for both males and females. The selected doses were prepared by mixing weighed portions of purina Lab Chow in meal form with weighed portions of the test material. 12 % water was added to the test material as a dust control agent prior to mixing with the meal. For each dose level, one weekly lot of 4500 g (+ 12 % water compensation) was prepared.
The actual mixtures were composed of the following ingredients:
- Dose level 5.0 % (w/w): 252 g test material and water + 4275 g meal
- Dose level 2.5 % (w/w): 126 g test material and water + 4387.5 g meal
- Dose level 1.25 % (w/w): 63 g test material and water + 4443.75 g meal
- Dose level 0.6 % (w/w): 30.24 g test material and water + 44735 g meal
- Dose level 0.3 % (w/w): 15.12 g test material and water + 4486.5 g meal
Each diet was mixed in a Patterson-Kelly twin shelled V blender for 15 min.
The doses were mixed one or two days prior to the week of their use in the study, and stored at 23 °C.
One analysis was perfomed to determine the accuracy of the mixture concentration. - Duration and frequency of treatment / exposure:
- 90 days
- Dose / conc.:
- 0.3 other: % in the diet
- Dose / conc.:
- 0.6 other: % in the diet
- Dose / conc.:
- 1.25 other: % in the diet
- Dose / conc.:
- 2.5 other: % in the diet
- Dose / conc.:
- 5 other: 5% in the diet
- No. of animals per sex per dose / concentration:
- 10 males and 10 females per dose
- Control animals:
- yes, plain diet
- Details on study design:
- - 10 animals were used per sex and dose group.
- Five dose levels of 0.0, 0.3, 0.6, 1.25 and 5.0 % in feed were used in this study (approx. 1000, 2000, 4000, 8000 and 16000 mg/kg bw for males [based on 7.3 g/d average food consumption, 0.023 kg average bw] and approx. 1100, 2200, 4700, 9300 and 18700 mg/kg bw for females [based on 7.1 g/d average food consumption, 0.019 kg average bw], respectively).
- The selected doses were prepared by mixing together weighed portions of Purina Lab Chow in meal form with weighed portions of the chemical. 12% water was added to the chemical as a dust control agent prior to mixing with the meal.
- Each dosed group received on 91 consecutive days of dosed feed mixture.
- Mice were necropsied on day 92 and 93.
Copper analyses were completed in the liver and kidney tissues and the formalin preserving those tissues from male mice in the highest dose group (5 % w/w) and control groups:
- Tissue samples were prepared for analysis by digesting in 10 ml of concentrated nitric acid until most of the organic material was destroyed. Perchloric acid was then added and the solutions were evaporated to strong fumes, additional nitric acid being added as required. The solutions were then fumed to dryness, the residues were dissolved in 5 % nitric acid and the solutions were diluted to 10 ml.
- Formalin samples were filtered through a Millex-GS 0.22 µm filter unit and 5 ml portions of each sample were prepared for analysis by the procedure used to prepare the tissue samples.
- The samples were then subjected to atomic absorption spectrophotometry to determine copper content:
A Perkin-Elmer Model 5000 atomic absorption spectrophotometer was utilized for the work. A series of 10 ml standard solutions, ranging from 0.05 to 2.0 ppm were prepared in 5 % nitric acid by dilution of a certified standard copper stock solution. These solutions were used to calibrate the instrument, which was programmed to print out data as total microgramms of copper per sample. The prepared sample solutions were used in the same manner as the standards. Concentrations of copper in the tissue samples were calculated by dividing the total microgramms found by the weight of the sample. Concentrations of copper in the formalin samples were calculated on a volume basis. - Statistics:
- Student´s T-test (alpha = 0.05) was used to compare the highest dose group results with control results.
- Preliminary studies:
- No data given.
- Details on absorption:
- No data given.
- Details on distribution in tissues:
- Slight, but statistically significant increases of copper incorporation were reported in the liver tissues (3.98 ppm +- 1.16 ppm; p < 0.05) and kidney (7.47 ppm +- 2.86 ppm; p < 0.05) tissues of treated male animals of the highest dose group, compared to controls (liver: 3.0 ppm +- 0.34 ppm; kidney: 4.66 ppm +- 0.6 ppm). From all the formalin analyses performed, the authors drawed the conclusion that no detectable levels of copper were leached from the preserved tissue into the formalin bath.
However, an evaluation of the results was conducted by expert judgement and the author draw the following conclusions:
The results of the study do not provide unequivocal evidence for a lack of absorption of the test material. However, the total lack of findings during the 13 week study, coupled with the insolubility of the test material and the minimal changes in tissue copper residues strongly suggests that the test material was not appreciably absorbed.
- Details on excretion:
- No data given.
- Metabolites identified:
- not measured
- Details on metabolites:
- No data given.
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Objective of study:
- distribution
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- At the end of 90-feeding of mice, copper analyses were conducted in livers and kidneys of the animals.
- GLP compliance:
- no
- Specific details on test material used for the study:
- - Name of test material (as cited in study report): Green 7 (C54637)
- Analytical purity: 97.8 % - Radiolabelling:
- no
- Species:
- mouse
- Strain:
- B6C3F1
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Industries
- Age at study initiation: 8.5 weeks
- Weight at study initiation: males: 20 - 24 g; females: 15 - 18 g
- Housing: polycarbonate cages: groups of 5 mice per cage
- Diet: weighed portions of Purina Lab Chow in meal form, mixed together with weighed portions of the test material (see details at "doses/concentrations")
- Water: ad libitum
- Acclimation period: 15 days
ENVIRONMENTAL CONDITIONS
- Temperature: 21 - 23 °C
- Humidity: 40 - 60 %
- Air changes: at least 15 per hour
- Photoperiod: 12 hrs dark / 12 hrs light - Route of administration:
- oral: feed
- Vehicle:
- unchanged (no vehicle)
- Details on exposure:
- Dose levels of 5.0, 2.5, 1.25, 0.6 and 0.3 % (w/w) were selected for both males and females. The selected doses were prepared by mixing weighed portions of purina Lab Chow in meal form with weighed portions of the test material. For each dose level, one weekly lot of 4500 g was prepared.
The actual mixtures were composed of the following ingredients:
- Dose level 5.0 % (w/w): 225 g test material and water + 4275 g meal
- Dose level 2.5 % (w/w): 112.5 g test material and water + 4387.5 g meal
- Dose level 1.25 % (w/w): 56.25 g test material and water + 4443.75 g meal
- Dose level 0.6 % (w/w): 27 g test material and water + 44735 g meal
- Dose level 0.3 % (w/w): 13.5 g test material and water + 4486.5 g meal
Each diet was mixed in a Patterson-Kelly twin shelled V blender for 15 min.
The doses were mixed one or two days prior to the week of their use in the study, and stored at 23 °C.
One analysis was perfomed to determine the accuracy of the mixture concentration. - Duration and frequency of treatment / exposure:
- 90 day(s)
- Dose / conc.:
- 0.3 other: % in the diet
- Dose / conc.:
- 0.6 other: % in the diet
- Dose / conc.:
- 1.25 other: % in the diet
- Dose / conc.:
- 2.5 other: % in the diet
- Dose / conc.:
- 5 other: % in the diet
- No. of animals per sex per dose / concentration:
- 10 males and 10 females per dose
- Control animals:
- yes, plain diet
- Details on study design:
- - 10 animals were used per sex and dose group.
- Five dose levels of 0.0, 0.3, 0.6, 1.25 and 5.0 % in feed were used in this study (approx. 1000, 2000, 4000, 8000 and 16000 mg/kg bw for males [based on 7.3 g/d average food consumption, 0.023 kg average bw] and approx. 1100, 2200, 4700, 9300 and 18700 mg/kg bw for females [based on 7.1 g/d average food consumption, 0.019 kg average bw], respectively).
- The selected doses were prepared by mixing together weighed portions of Purina Lab Chow in meal form with weighed portions of the chemical. 12% water was added to the chemical as a dust control agent prior to mixing with the meal.
- Each dosed group received on 91 consecutive days of dosed feed mixture.
- Mice were necropsied on day 92 and 93.
Copper analyses were completed in the liver and kidney tissues and the formalin preserving those tissues from male mice in the highest dose group (5 % w/w) and control groups:
- Tissue samples were prepared for analysis by digesting in 10 ml of concentrated nitric acid until most of the organic material was destroyed. Perchloric acid was then added and the solutions were evaporated to strong fumes, additional nitric acid being added as required. The solutions were then fumed to dryness, the residues were dissolved in 5 % nitric acid and the solutions were diluted to 10 ml.
- Formalin samples were filtered through a Millex-GS 0.22 µm filter unit and 5 ml portions of each sample were prepared for analysis by the procedure used to prepare the tissue samples.
- The samples were then subjected to atomic absorption spectrophotometry to determine copper content:
A Perkin-Elmer Model 5000 atomic absorption spectrophotometer was utilized for the work. A series of 10 ml standard solutions, ranging from 0.05 to 2.0 ppm were prepared in 5 % nitric acid by dilution of a certified standard copper stock solution. These solutions were used to calibrate the instrument, which was programmed to print out data as total microgramms of copper per sample. The prepared sample solutions were used in the same manner as the standards. Concentrations of copper in the tissue samples were calculated by dividing the total microgramms found by the weight of the sample. Concentrations of copper in the formalin samples were calculated on a volume basis. - Statistics:
- Student´s T-test (alpha = 0.05) was used to compare the highest dose group results with control results.
- Preliminary studies:
- No data given.
- Details on absorption:
- No data given.
- Details on distribution in tissues:
- Copper content of liver: 5.56 +/- 3.22 ppm (Test group) and 4.11 +/- 1.60 ppm (control)
Content of kidney: 6.57 +/- 1.9 ppm (Test group) and 4.04 +/- 0.8 ppm (control)
It was suggested that free copper, present as minor impurity in the pigment was responsible for the slight increase in tissue copper levels
that were noted. From all the formalin analyses performed, the authors concluded that no detectable levels of copper were leached from the preserved tissue into the formalin bath. - Details on excretion:
- No data given.
- Metabolites identified:
- no
- Details on metabolites:
- No data given.
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Reason / purpose for cross-reference:
- reference to same study
- Objective of study:
- distribution
- Qualifier:
- no guideline required
- Principles of method if other than guideline:
- Determination of copper content in liver and kidney at the end of a 90 day feeding study with up to 5% in the diet.
- GLP compliance:
- no
- Specific details on test material used for the study:
- - Name of test material (as cited in study report): Green 7 (C54637)
- Analytical purity: 97.8 % - Radiolabelling:
- no
- Species:
- rat
- Strain:
- Fischer 344
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS:
- Source: Harlan Industries
- Weight at study initiation: males: 70 - 105 g; females: 70 - 100 g
- Housing: polycarbonate cages: groups of 5 rats per cage
- Diet: weighed portions of Purina Lab Chow in meal form, mixed together with weighed portions of the test material (see details at "doses/concentrations")
- Water: ad libitum
- Acclimation period: 15 days
ENVIRONMENTAL CONDITIONS:
- Temperature: 21 - 23 °C
- Humidity: 40 - 60 %
- Air changes: at least 15 per hour
- Photoperiod: 12 hrs dark / 12 hrs light - Route of administration:
- oral: feed
- Vehicle:
- unchanged (no vehicle)
- Details on exposure:
- Dose levels of 5.0, 2.5, 1.25, 0.6 and 0.3 % (w/w) were selected for both males and females. The selected doses were prepared by mixing weighed portions of purina Lab Chow in meal form with weighed portions of the test material. For each dose level, one weekly lot of 4500 g was prepared.
The actual mixtures were composed of the following ingredients:
- Dose level 5.0 % (w/w): 225 g test material and water + 4275 g meal
- Dose level 2.5 % (w/w): 112.5 g test material and water + 4387.5 g meal
- Dose level 1.25 % (w/w): 56.25 g test material and water + 4443.75 g meal
- Dose level 0.6 % (w/w): 27 g test material and water + 44735 g meal
- Dose level 0.3 % (w/w): 13.5 g test material and water + 4486.5 g meal
Each diet was mixed in a Patterson-Kelly twin shelled V blender for 15 min.
The doses were mixed one or two days prior to the week of their use in the study, and stored at 23 °C.
One analysis was perfomed to determine the accuracy of the mixture concentration. - Duration and frequency of treatment / exposure:
- 90 days
- Dose / conc.:
- 0.3 other: % in the diet
- Remarks:
- ca 300 mg/kg bw
- Dose / conc.:
- 0.6 other: % in the diet
- Dose / conc.:
- 1.25 other: % in the diet
- Dose / conc.:
- 2.5 other: % in the diet
- Dose / conc.:
- 5 other: % in the diet
- No. of animals per sex per dose / concentration:
- Males: 10 Females: 10
- Control animals:
- yes, plain diet
- Details on study design:
- The concentrations of the chemical mixture were the same for male and female rats. All dose levels were prepared on a weight per weight basis. There were 5 dose level groups with 10 individuals of each sex in each dosage and control group. Each dosed group received 90 consecutive days of dosed feed mixture. After one day of observation, the animals were necropsied. Animals were observed twice each day for clinical signs, with at least 6 hours between observations. All observations were recorded daily. Additionally, blood sampling was conducted from 10 control rats, 5 males and 5 females.
Copper analyses were completed in the liver and kidney tissues and the formalin preserving those tissues from male rats in the highest dose group (5 % w/w) and control groups:
- Tissue samples were prepared for analysis by digesting in 10 ml of concentrated nitric acid until most of the organic material was destroyed. Perchloric acid was then added and the solutions were evaporated to strong fumes, additional nitric acid being added as required. The solutions were then fumed to dryness, the residues were dissolved in 5 % nitric acid and the solutions were diluted to 10 ml.
- Formalin samples were filtered through a Millex-GS 0.22 µm filter unit and 5 ml portions of each sample were prepared for analysis by the procedure used to prepare the tissue samples.
- The samples were then subjected to atomic absorption spectrophotometry to determine copper content:
A Perkin-Elmer Model 5000 atomic absorption spectrophotometer was utilized for the work. A series of 10 ml standard solutions, ranging from 0.05 to 2.0 ppm were prepared in 5 % nitric acid by dilution of a certified standard copper stock solution. These solutions were used to calibrate the instrument, which was programmed to print out data as total microgramms of copper per sample. The prepared sample solutions were used in the same manner as the standards. Concentrations of copper in the tissue samples were calculated by dividing the total microgramms found by the weight of the sample. Concentrations of copper in the formalin samples were calculated on a volume basis. - Details on dosing and sampling:
- PHARMACOKINETIC STUDY (distribution)
- Tissues and body fluids sampled: liver and kidneys - Statistics:
- Student´s T-test (alpha = 0.05) was used to compare the highest dose group results with control results.
- Type:
- absorption
- Results:
- No systemic uptake after ingestion
- Details on distribution in tissues:
- Copper content of liver: 4.28 +/- 1.1 (Test group) and 3.08 +/- 0.39 ppm (control group)
Copper content of kidney: 8.23 +/- 1.75 (Test group) and 4.68 +/- 0.82 ppm (control group).
An evaluation of these results led the authors to the conclusion, that it is unlikely that the test material was appreciably resorbed from the gastrointestinal tract due to its insolubility and chemical inertness. It was rather suggested that free copper, present as minor impurity in the pigment was responsible for the slight increase in tissue copper levels that were noted.
From all the formalin analyses performed, the authors concluded that no detectable levels of copper were leached from the preserved tissue into the formalin bath. - Metabolites identified:
- no
- Details on metabolites:
- No data given.
Referenceopen allclose all
The test material did not show significant solubility (0.4 % of the initial amount dissolved within 7 days in phagolysosomal simulant fluid at pH 4.5 and a continuous flow-rate of 2 mL/h).
The analysis of changes during dissolution showed, that the test material tended to form aggregates, as no smaller particles remained.
Table 1: Copper determinations in tissues and formalin of male rats from the subchronic study, treated with the test material for 90 days
male animal # |
ppm copper |
|
||
|
liver |
kidney |
formalin |
remark |
highest dose group (5 % w/w) |
|
|
|
|
1 |
4.6 - 4.3* |
8.4 |
0.1 |
* results of 2 analyses |
2 |
5.9 |
12.3 |
0.1 |
|
3 |
4.1 - 4.4* |
8.6 - 10.1* |
0.1 |
* results of 2 analyses |
4 |
6.4 |
7.7 |
0.1 |
|
5 |
3.2 |
6.7 |
0.1 |
|
6 |
3.5 |
5.8 |
0.1 |
|
7 |
3.7 |
8.1 |
0.1 |
|
8 |
3.5 - 4.1 |
8.1 |
0.1 |
|
9 |
3.1 |
8.7 - 8.6* |
0.1 |
* results of 2 analyses |
10 |
4.6 - 4.5 |
7.2 |
0.1 |
|
control |
|
|
|
|
1 |
3.1 |
3.7 - 4.0* |
0.1 |
* results of 2 analyses |
2 |
3.3 |
4.1 |
0.1 |
|
3 |
3.2 |
4.9 - 4.6* |
0.1 |
* results of 2 analyses |
4 |
3.7 - 4.0* |
5.1 |
0.1 |
* results of 2 analyses |
5 |
3.0 |
4.1 |
0.1 |
|
6 |
2.8 |
5.4 |
0.1 |
|
7 |
2.9 |
2.9 - 3.4* |
0.1 |
* results of 2 analyses |
8 |
2.6 |
5.5 |
0.1 |
|
9 |
2.6 |
5.4 |
0.1 |
|
10 |
3.3 - 3.6* |
5.4 |
0.1 |
* results of 2 analyses |
Table 1: Copper determinations in tissues and formalin of male mice from the subchronic study, treated with the test material for 91 days
male animal # |
ppm copper |
|
||
|
liver |
kidney |
formalin |
remark |
highest dose group (5 % w/w) |
|
|
|
|
1 |
7.0 |
14.5 |
-- |
|
2 |
3.2-3.6 * |
6.8 |
-- |
* results of 2 analyses |
3 |
3.4 |
7.7 |
-- |
|
4 |
3.4 |
4.8 |
-- |
|
5 |
3.5 |
6.3 |
-- |
|
6 |
3.7 |
7.3 |
-- |
|
7 |
3.9 |
6.4 |
-- |
|
8 |
4.1 |
8.2 |
-- |
|
9 |
3.3-3.6 * |
5.2 |
-- |
* results of 2 analyses |
control |
|
|
|
|
1 |
3.5 |
4.2 |
0.1 |
|
2 |
3.1 |
3.8 |
0.1 |
|
3 |
3.1 |
4.6 |
0.1 |
|
4 |
2.8 |
4.6 |
0.1 |
|
5 |
2.9 |
4.2 |
0.1 |
|
6 |
3.2 |
4.7 |
0.1 |
|
7 |
3.2 |
5.8 |
0.1 |
|
8 |
2.9 |
5.3 |
0.1 |
|
9 |
2.3 |
4.7 |
0.1 |
|
Table 1: Copper determinations in tissues and formalin of mice from the subchronic study, treated with the test material for 90 days
male animal # |
ppm copper |
|
||
|
liver |
kidney |
formalin |
remark |
highest dose group (5 % w/w) |
|
|
|
|
1 |
2.9 |
4.4 |
- |
|
2 |
4.6 |
6.0 |
< 0.1 |
|
3 |
3.2 |
4.7 |
< 0.1 |
|
4 |
4.1 |
6.3 |
< 0.1 |
|
5 |
3.9 |
4.8 |
< 0.1 |
|
6 |
5.5 |
8.8 |
< 0.1 |
|
7 |
7.2 |
7.0 |
< 0.1 |
|
8 |
3.4 |
5.5 |
< 0.1 |
|
9 |
7.2 |
8.2 |
< 0.1 |
|
10 |
13.6 |
10.0 |
< 0.1 |
|
control |
|
|
|
|
1 |
- |
- |
- |
|
2 |
8.0 |
3.3 |
< 0.1 |
|
3 |
3.3 - 3.5* |
3.5 |
< 0.1 |
Results of 2 analyses |
4 |
4.3 |
4.1 |
< 0.1 |
|
5 |
2.7 |
3.1 |
< 0.1 |
|
6 |
4.1 |
5.6 |
< 0.1 |
|
7 |
4.5 |
4.0 |
< 0.1 |
|
8 |
3.8 |
5.0 |
< 0.1 |
|
9 |
3.6 |
4.0 |
< 0.1 |
|
10 |
2.6 |
3.8 |
< 0.1 |
Table 1: Copper determinations in tissues and formalin of male rats from the subchronic study, treated with the test material for 90 days
male animal # |
ppm copper |
|
||
|
liver |
kidney |
formalin |
remark |
highest dose group (5 % w/w) |
|
|
|
|
1 |
4.6 - 4.3* |
8.4 |
< 0.1 |
* Results of 2 analyses |
2 |
5.9 |
12.3 |
< 0.1 |
|
3 |
4.1 - 4.4* |
8.6 - 10.1* |
< 0.1 |
* Results of 2 analyses |
4 |
6.4 |
7.7 |
< 0.1 |
|
5 |
3.2 |
6.7 |
< 0.1 |
|
6 |
3.5 |
5.8 |
< 0.1 |
|
7 |
3.7 |
8.1 |
< 0.1 |
|
8 |
3.5 - 4.1* |
8.1 |
< 0.1 |
* Results of 2 analyses |
9 |
3.1 |
8.7 - 8.6* |
< 0.1 |
* Results of 2 analyses |
10 |
4.6 - 4.5 |
7.2 |
< 0.1 |
* Results of 2 analyses |
control |
|
|
|
|
1 |
3.1 |
3.7 - 4.0* |
< 0.1 |
* Results of 2 analyses |
2 |
3.3 |
4.1 |
< 0.1 |
|
3 |
3.2 |
4.9 - 4.6* |
< 0.1 |
* Results of 2 analyses |
4 |
3.7 - 4.0* |
5.1 |
< 0.1 |
* Results of 2 analyses |
5 |
3.0 |
4.1 |
< 0.1 |
|
6 |
2.8 |
5.4 |
< 0.1 |
|
7 |
2.9 |
2.9 - 3.4* |
< 0.1 |
* Results of 2 analyses |
8 |
2.6 |
5.5 |
< 0.1 |
|
9 |
2.6 |
5.4 |
< 0.1 |
|
10 |
3.3 - 3.6* |
5.4 |
< 0.1 |
* Results of 2 analyses |
Description of key information
Organic pigments have shown no indication for systemic uptake unless they contain groups susceptible to acid-catalysed hydrolysis (Stratmann et al 2020). The existing data for Pigment Blue 16 is in support of this. Further studies such as the dynamic dissolution are ongoing. Standard testing of water solubility was performed using a filtration step with a cut-off pore-size of 200 nm. This results in the detection of dispersed particles via total organic carbon content at 1.6 mg/L with a loading rate of 1g/L and 9.1 mg/L with a loading rate of 10g/L. of < 10 mg/L
The dispersion stability of Pigment Blue 16 in was strongly depended on pH and water hardness. Dissolution was excluded as the main cause of the apparent stability. At pH 7 in 0 mM Calcium ions the stability was high. At pH 7 and 9 in 0 mM Ca2+ and at pH 4-9 in 1 mM Ca2+ the stability was intermediate. For the samples in 10 mM Ca2+ the stability was low at any pH value (4, 7 and 9).
Experimental data on two phthalocyanine pigments is summarised as follows:
CAS 147-14-8
Oral: Rat: No statistically significant increases of copper incorporation in the liver and kidney tissues of treated male animals after exposure to 5 % copper phthalocyanine in the diet (approx. 4600 mg/kg bw), administered on 90 consecutive days (Batelle 1979, K2).
Oral: Mouse: Slight, but statistically significant increases of copper incorporation in the liver and kidney tissues of treated male animals of the highest dose group compared to controls after exposure to 5 % copper phthalocyanine in the diet (approx. 16000 mg/kg bw), administered on 90 consecutive days (Batelle 1979, K2).
CAS 1328-53-6
Oral: Rat: Slight, but statistically significant increases of copper incorporation in the liver and kidney tissues of treated male animals of the highest dose group after exposure to 5 % Polychloro copper phthalocyanine in the diet (approx. 4600 mg/kg bw), administered on 90 consecutive days (Batelle 1979, K2).
Oral: Mouse: Slight, but statistically significant increases of copper incorporation in the kidney tissues, but not in the livers of treated male animals of the highest dose group after exposure to 5 % Polychloro copper phthalocyanine in the diet (approx. 16000 mg/kg bw), administered on 90 consecutive days (Batelle 1979, K2).
Reference
H. Stratmann, M. Hellmund, U. Veith, N. End and W.Teubner: Indicators for lack of systemic availability of organic pigments. Regulatory Toxicology and Pharmacology (2020), Vol 115, 104719
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
CAS 147-14-8
There are valid experimental data available to assess relevant toxikokinetic (distribution) informations of copper phthalocyanine. Concentrations of copper phthalocyanine were analyzed in liver and kidney of male rats and mice after oral exposure in a subchronic 90-day feeding study. The concentrations were 0.3 %, 0.6 %, 1.25 %, 2.5 % and 5 % in the diet for rats (corresponding to approx. 0, 250, 500, 1100, 2200 and 4500 mg/kg bw for both sexes [based on 16.4 g/d average food consumption, 0.182 kg average bw for males and on 11.55 g/d average food consumption, 0.130 kg average bw] for females) and mice (approx. 0, 1000, 2000, 4000, 8000 and 16000 mg/kg bw for males [based on 7.3 g/d average food consumption, 0.023 kg average bw] and approx. 0, 1100, 2200, 4700, 9400 and 18700 mg/kg bw for females [based on 7.1 g/d average food consumption, 0.019 kg average bw], respectively), administered on 90 consecutive days. The liver and kidney tissues from the highest dose and from controls of male animals were dissolved in nitric acid and subsequently analyzed for copper by atomic absorption spectrophotometry. No statistically significant increases of copper incorporation were reported in the liver (2.82 ppm +- 0.34 ppm vs. 2.78 ppm +- 0.51 ppm) and kidney (5.62 ppm +- 0.49 ppm vs. 5.30 ppm +- 0.83 ppm) tissues of treated male rats of the highest dose group, compared to control animals. Therefore, the authors strongly suggested that the test material was not absorbed under the test conditions chosen. Slight, but statistically significant increases of copper incorporation were reported in the liver (3.98 ppm +- 1.16 ppm vs. 3.0 ppm +- 0.34 ppm) and kidney (7.47 ppm +- 2.86 ppm vs. 4.66 ppm +- 0.6 ppm) tissues of treated male mice, compared to control animals (Batelle 1979).
Another study with partially limited reliability (Koltermann-Jukky 2018) provided information on the copper content in the blood serum of rats, determined by the atomic-absorption method. The authorsof the study reported the following: No test material or products of its metabolism were detected in the blood of the animals. An increased Cu2+ content in the serum was connected to the content of soluble copper salts in the pigment. Treatment with purified test material did not alter the Cu2+ concentration in the serum of the animals.
CAS 1328-53-6
There are valid experimental data by Batelle (1979) available to assess relevant toxicokinetic (distribution) informations of polychloro copper phthalocyanine . Concentrations of polychloro copper phthalocyanine were analyzed in liver and kidney of male rats and mice after oral exposure in a subchronic 90-day feeding study. The concentrations were 0.3 %, 0.6 %, 1.25 %, 2.5 % and 5 % in the diet for rats (corresponding to approx. 0, 250, 500, 1100, 2200 and 4500 mg/kg bw for both sexes [based on 16.4 g/d average food consumption, 0.182 kg average bw for males and on 11.55 g/d average food consumption, 0.130 kg average bw] for females) and mice (approx. 0, 1000, 2000, 4000, 8000 and 16000 mg/kg bw for males [based on 7.3 g/d average food consumption, 0.023 kg average bw] and approx. 0, 1100, 2200, 4700, 9400 and 18700 mg/kg bw for females [based on 7.1 g/d average food consumption, 0.019 kg average bw], respectively), administered on 90 consecutive days. The liver and kidney tissues from the highest dose and from controls were dissolved in nitric acid and subsequently analyzed for copper by atomic absorption spectrophotometry. Polychloro copper phthalocyanine produced slight, but statistically significant increases in the copper levels in rat liver (4.28 +- 1.1 vs. 3.08 +- 0.39 ppm) and kidney (8.23 +- 1.75 vs. 4.68 +- 0.82 ppm) as well as in mouse kidney (6.57 +- 1.9 vs. 4.04 +- 0.8 ppm). Copper levels in mouse liver were not altered.
Within the framework of an expert judgement, the evaluating author strongly suggested that the test material was not appreciably absorbed under the test conditions chosen with the following justification: The reported minor changes in tissue levels indicate a small exposure of the organs to copper. Changes were always less than two fold. Absorption of the substance by the gastrointestinal tract is considered to be unlikely since polychloro copper phthalocyanine is of high molecular weight, insoluble in aqueous media and chemically inert. This suggests that free copper, present as a minor impurity in the pigment, is responsible for the slight increases in tissue copper levels that were noted (Assessment from Dr. Mennear JH, Expert Toxicologist to Dr. Moore JA, Deputy Director NTP).
Additionally, bioaccumulation of copper ion released by Polychloro copper phthalocyanine was considered to be unlikely, as it does not appear to be available from phthalocyanine pigments (Federal Register, 1991).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.